Interferon regulatory factor 7 alleviates the experimental colitis through enhancing IL-28A-mediated intestinal epithelial integrity

Furong Qing,Hongbo Tian,Biyao Wang,Bingyu Xie,Lina Sui,Xiaoyan Xie,Wenji He,Tiansheng He,Yumei Li,Liangmei He,Qin Guo,Zhiping Liu
DOI: https://doi.org/10.1186/s12967-024-05673-y
IF: 8.44
2024-10-09
Journal of Translational Medicine
Abstract:The incidence of inflammatory bowel disease (IBD) is on the rise in developing countries, and investigating the underlying mechanisms of IBD is essential for the development of targeted therapeutic interventions. Interferon regulatory factor 7 (IRF7) is known to exert pro-inflammatory effects in various autoimmune diseases, yet its precise role in the development of colitis remains unclear.
medicine, research & experimental
What problem does this paper attempt to address?